RxDoctor Payments DataLook up a doctor →

Steve Chang, MD

Internal Medicine · New Berlin, WINPI 1295897569

Payments from drug & device makers

$21,146in general payments, 2019–2025

Across 1,096 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Lilly USA, LLC$2K
  • AbbVie$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • Boehringer Ingelheim$1K
  • plus $11K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk138$2,572
Lilly USA, LLC90$1,774
AbbVie(2 entities)102$1,669
AstraZeneca74$1,404
Pfizer65$1,349
Boehringer Ingelheim59$1,232
Astellas Pharma US Inc34$947
Amneal Pharmaceuticals LLC51$906
Johnson & Johnson49$805
UCB, Inc.27$725
Novartis39$725
Sunovion Pharmaceuticals Inc.45$686
Otsuka America Pharmaceutical, Inc.30$574
E.r. Squibb & Sons, L.L.C.20$547
Bayer25$503
Neurocrine Biosciences, Inc.17$401
Teva Pharmaceuticals USA, Inc.19$391
Neurelis, Inc.17$386
Acadia Pharmaceuticals Inc17$285
Avanir Pharmaceuticals, Inc.15$284
Eisai Inc.12$212
Exact Sciences10$190
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$189
Scilex Pharmaceuticals Inc.11$184
Sumitomo Pharma America, Inc.10$184
Amgen9$166
SK Life Science, Inc.8$163
Lundbeck LLC7$150
Collegium Pharmaceutical, Inc.7$143
Nestle Healthcare Nutrition Inc.8$143
Takeda Pharmaceuticals U.S.A., Inc.10$125
Amarin Pharma, Inc.7$109
Biohaven Pharmaceutical Holding Company Ltd.5$90
Kyowa Kirin, Inc.4$90
GSK4$86
Merck4$68
Boston Scientific3$67
Arbor Pharmaceuticals, Inc.4$65
Ardelyx, Inc.3$61
Dexcom, Inc.2$44
IBSA Pharma Inc.3$40
Acorda Therapeutics, Inc2$39
Paratek Pharmaceuticals, Inc.2$35
Amphastar Pharmaceuticals, Inc.1$35
Alkermes, Inc.1$35
Inspire Medical Systems, Inc.1$32
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$31
Mylan Specialty L.p.2$29
Mallinckrodt Hospital Products Inc.1$26
Almatica Pharma LLC1$24
Genentech USA, Inc.1$23
GE HealthCare1$23
OPKO Pharmaceuticals, LLC1$20
Kowa Pharmaceuticals America, Inc.1$19
Abbott1$17
Medtronic1$16
Biohaven Pharmaceuticals, Inc.1$12

How this compares

$21,146 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.

See all internal medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$196,000
Medicare patients
473
Services billed
1,981

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in New Berlin

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →